162 related articles for article (PubMed ID: 7637259)
1. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat.
Lan HY; Nikolic-Paterson DJ; Mu W; Vannice JL; Atkins RC
Kidney Int; 1995 May; 47(5):1303-9. PubMed ID: 7637259
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist.
Lan HY; Nikolic-Paterson DJ; Zarama M; Vannice JL; Atkins RC
Kidney Int; 1993 Feb; 43(2):479-85. PubMed ID: 8441245
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
Tang WW; Feng L; Vannice JL; Wilson CB
J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
[TBL] [Abstract][Full Text] [Related]
4. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat.
Yu XQ; Fan JM; Nikolic-Paterson DJ; Yang N; Mu W; Pichler R; Johnson RJ; Atkins RC; Lan HY
Am J Pathol; 1999 Mar; 154(3):833-41. PubMed ID: 10079261
[TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental glomerulonephritis by the interleukin-1 receptor antagonist: inhibition of intercellular adhesion molecule-1 expression.
Nikolic-Paterson DJ; Lan HY; Hill PA; Vannice JL; Atkins RC
J Am Soc Nephrol; 1994 Mar; 4(9):1695-700. PubMed ID: 7516723
[TBL] [Abstract][Full Text] [Related]
6. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice.
Chen A; Sheu LF; Chou WY; Tsai SC; Chang DM; Liang SC; Lin FG; Lee WH
Am J Kidney Dis; 1997 Nov; 30(5):693-702. PubMed ID: 9370186
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
9. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production.
Yang N; Nikolic-Paterson DJ; Ng YY; Mu W; Metz C; Bacher M; Meinhardt A; Bucala R; Atkins RC; Lan HY
Mol Med; 1998 Jun; 4(6):413-24. PubMed ID: 10780884
[TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.
Chadban SJ; Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 1997 Jun; 51(6):1809-17. PubMed ID: 9186870
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonism.
Nikolic-Paterson DJ; Lan HY; Atkins RC
Semin Nephrol; 1996 Nov; 16(6):583-90. PubMed ID: 9125803
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
[TBL] [Abstract][Full Text] [Related]
13. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
Yu XQ; Nikolic-Paterson DJ; Mu W; Giachelli CM; Atkins RC; Johnson RJ; Lan HY
Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
15. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Lan HY; Bacher M; Yang N; Mu W; Nikolic-Paterson DJ; Metz C; Meinhardt A; Bucala R; Atkins RC
J Exp Med; 1997 Apr; 185(8):1455-65. PubMed ID: 9126926
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis.
Timoshanko JR; Kitching AR; Iwakura Y; Holdsworth SR; Tipping PG
Am J Pathol; 2004 Jun; 164(6):1967-77. PubMed ID: 15161633
[TBL] [Abstract][Full Text] [Related]
17. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Atkins RC
Lab Invest; 1992 Dec; 67(6):743-51. PubMed ID: 1460865
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
Lan HY; Yang N; Metz C; Mu W; Song Q; Nikolic-Paterson DJ; Bacher M; Bucala R; Atkins RC
Mol Med; 1997 Feb; 3(2):136-44. PubMed ID: 9085256
[TBL] [Abstract][Full Text] [Related]
19. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
Liu D; Nazneen A; Taguchi T; Razzaque MS
Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental crescentic glomerulonephritis by deoxyspergualin.
Lan HY; Zarama M; Nikolic-Paterson DJ; Kerr PG; Atkins RC
J Am Soc Nephrol; 1993 May; 3(11):1765-74. PubMed ID: 8329671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
